SEARCH

SEARCH BY CITATION

References

  • Abe, M., Hiura, K., Wilde, J., Shioyasono, A., Moriyama, K., Hashimoto, T., Kido, S., Oshima, T., Shibata, H., Ozaki, S., Inoue, D. & Matsumoto, T. (2004) Osteoclasts enhance myeloma cell growth and survival via cell–cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood, 104, 24842491.
  • Adatia, A.K. (1968) Response of the dental elements to chemotherapy of Burkitt's tumour. International Dental Journal, 18, 646654.
  • Alford, A.I. & Hankenson, K.D. (2006) Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone, 38, 749757.
  • Angelucci, A., Festuccia, C., Gravina, G.L., Muzi, P., Bonghi, L., Vicentini, C. & Bologna, M. (2004) Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate, 59, 157166.
  • Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G.Y. & Suda, T. (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell, 118, 149161.
  • Asou, Y., Rittling, S.R., Yoshitake, H., Tsuji, K., Shinomiya, K., Nifuji, A., Denhardt, D.T. & Noda, M. (2001) Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology, 142, 13251332.
  • Barber, L., Miles Prince, H., Rossi, R. & Bertoncello, I. (1999) Fluro-Gold: an alternative viability stain for multicolor flow cytometric analysis. Cytometry, 36, 349354.
  • Barry, S.T., Ludbrook, S.B., Murrison, E. & Horgan, C.M.T. (2000) A regulated interaction between α5β1 integrin and osteopontin. Biochemical and Biophysical Research Communications, 267, 764769.
  • Bayless, K.J., Meinenger, G.A., Scholtz, J.M. & Davis, G.E. (1998) Osteopontin is a ligand for the α4β1 integrin. Journal of Cell Science, 111, 11651174.
  • Behrend, E.I., Craig, A.M., Wilson, S.M., Denhardt, D.T. & Chambers, A.F. (1994) Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Research, 54, 832837.
  • Butler, W.T. (1989) The nature and significance of osteopontin. Connective Tissue Research, 23, 123136.
  • Calvi, L.M., Adams, G.B., Weibrecht, K.W., Weber, J.M., Olson, D.P., Knight, M.C., Martin, R.P., Schipani, E., Divieti, P., Bringhurst, F.R., Milner, L.A., Kronenberg, H.M. & Scadden, D.T. (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature, 425, 841846.
  • Chambers, A.F., Behrend, E.I., Wilson, S.M. & Denhardt, D.T. (1992) Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Research, 12, 4347.
  • Chang, P.L. & Prince, C.W. (1993) 1 alpha,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate-induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells. Cancer Research, 53, 22172220.
  • Charbord, P., Tavian, M., Humeau, L. & Peault, B. (1996) Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microenvironment. Blood, 87, 41094119.
  • Cheriyath, V. & Hussein, M.A. (2005) Osteopontin, angiogenesis and multiple myeloma. Leukemia, 19, 22032205.
  • Colla, S., Morandi, F., Lazzaretti, M., Rizzato, R., Lunghi, P., Bonomini, S., Mancini, C., Pedrazzoni, M., Crugnola, M., Rizzoli, V. & Giuliani, N. (2005) Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia, 19, 21662176.
  • Denhardt, D.T. & Guo, X. (1993) Osteopontin: a protein with diverse functions. FASEB Journal, 7, 14751482.
  • Denhardt, D.T., Noda, M., O'Regan, A.W., Pavlin, D. & Berman, J.S. (2001a) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. Journal of Clinical Investigation, 107, 10551061.
  • Denhardt, D.T., Giachelli, C.M. & Rittling, S.R. (2001b) Role of osteopontin in cellular signaling and toxicant injury. Annual Review of Pharmacology and Toxicology, 41, 723749.
  • Ek-Rylander, B., Flores, M., Wendel, M., Heinegard, D. & Andersson, G. (1994) Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. Journal of Biological Chemistry, 269, 1485314856.
  • El-Badri, N.S., Wang, B.Y., Cherry & Good, R.A. (1998) Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Experimental Hematology, 26, 110116.
  • Flamant, S., Kortulewski, T., Dugray, A., Bonnet, M.L., Guillier, M., Guilhot, F., Bourhis, J.H., Vainchenker, W., Tronik-Le Roux, D. & Turhan, A.G. (2005) Osteopontin is upregulated by BCR-ABL. Biochemical and Biophysical Research Communications, 333, 13781384.
  • Franzen, A. & Heinegard, D. (1985) Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochemical Journal, 232, 715724.
  • Giuliani, N., Colla, S., Lazzaretti, M., Sala, R., Roti, G., Mancini, C., Bonomini, S., Lunghi, P., Hojden, M., Genestreti, G., Svaldi, M., Coser, P., Fattori, P.P., Sammarelli, G., Gazzola, G.C., Bataille, R., Almici, C., Caramatti, C., Mangoni, L. & Rizzoli, V. (2003) Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood, 102, 638645.
  • Giuliani, N., Colla, S. & Rizzoli, V. (2004) Angiogenic switch in multiple myeloma. Hematology, 9, 377381.
  • Godin, I. & Cumano, A. (2002) The hare and the tortoise: an embryonic haematopoietic race. Nature Reviews. Immunology, 2, 593604.
  • Gong, J.K. (1978) Endosteal marrow: a rich source of hematopoietic stem cells. Science, 199, 14431445.
  • Green, P.M., Ludbrook, S.B., Miller, D.D., Horgan, C.M. & Barry, S.T. (2001) Structural elements of the osteopontin SVVYGLR motif important for the interaction with alpha(4) integrins. FEBS Letters, 503, 7579.
  • Greenfield, E.M., Horowitz, M.C. & Lavish, S.A. (1996) Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction. Journal of Biological Chemistry, 271, 1098410989.
  • Haylock, D.N. & Nilsson, S.K. (2005) Stem cell regulation by the hematopoietic stem cell niche. Cell Cycle, 4, 13531355.
  • Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N.R., Crystal, R.G., Besmer, P., Lyden, D., Moore, M.A., Werb, Z. & Rafii, S. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 109, 625637.
  • Heissig, B., Ohki, Y., Sato, Y., Rafii, S., Werb, Z. & Hattori, K. (2005) A role for niches in hematopoietic cell development. Hematology, 10, 247253.
  • Hickey, F.B., England, K. & Cotter, T.G. (2005) Bcr-Abl regulates osteopontin transcription via Ras, PI-3K, aPKC, Raf-1, and MEK. Journal of Leukocyte Biology, 78, 289300.
  • Hirama, M., Takahashi, F., Takahashi, K., Akutagawa, S., Shimizu, K., Soma, S., Shimanuki, Y., Nishio, K. & Fukuchi, Y. (2003) Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth. Cancer Letters, 198, 107117.
  • Hofbauer, L.C., Khosla, S., Dunstan, C.R., Lacey, D.L., Boyle, W.J. & Riggs, B.L. (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. Journal of Bone and Mineral Research, 15, 212.
  • Hu, D.D., Lin, E.C., Kovach, N.L., Hoyer, J.R. & Smith, J.W. (1995) A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. Journal of Biological Chemistry, 270, 2623226238.
  • Iwata, M., Awaya, N., Graf, L., Kahl, C. & Torok-Storb, B. (2004) Human marrow stromal cells activate monocytes to secrete osteopontin, which down-regulates Notch1 gene expression in CD34+ cells. Blood, 103, 44964502.
  • Katagiri, Y.U., Sleeman, J., Fujii, H., Herrlich, P., Hotta, H., Tanaka, K., Chikuma, S., Yagita, H., Okumura, K., Murakami, M., Saiki, I., Chambers, A.F. & Uede, T. (1999) CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Research, 59, 219226.
  • Katayama, Y., Hidalgo, A., Peired, A.J. & Frenette, P.S. (2004) Integrin alpha4beta7 and its counterreceptor MAdCAM-1 contribute to hematopoietic progenitor recruitment into bone marrow following transplantation. Blood, 104, 20202026.
  • Kiel, M.J., Yilmaz, O.H., Iwashita, T., Terhorst, C. & Morrison, S.J. (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell, 121, 11091121.
  • Kim, M.S., Park, M.J., Moon, E.J., Kim, S.J., Lee, C.H., Yoo, H., Shin, S.H., Song, E.S. & Lee, S.H. (2005) Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells. Cancer Research, 65, 686691.
  • Kubota, T., Zhang, Q., Wrana, J.L., Ber, R., Aubin, J.E., Butler, W.T. & Sodek, J. (1989) Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta. Biochemical and Biophysical Research Communications, 162, 14531459.
  • Levesque, J.P., Zannettino, A.C., Pudney, M., Niutta, S., Haylock, D.N., Snapp, K.R., Kansas, G.S., Berndt, M.C. & Simmons, P.J. (1999) PSGL-1-mediated adhesion of human hematopoietic progenitors to P- selectin results in suppression of hematopoiesis. Immunity, 11, 369378.
  • Liaw, L., Skinner, M.P., Raines, E.W., Ross, R., Cheresh, D.A., Schwartz, S.M. & Giachelli, C.M. (1995a) The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. Journal of Clinical Investigation, 95, 713724.
  • Liaw, L., Lindner, V., Schwartz, S.M., Chambers, A.F. & Giachelli, C.M. (1995b) Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circulation Research, 77, 665672.
  • Lin, Y., Huang, C., Chao, J., Chen, S., Lee, S., Yen, J.J. & Yang-Yen, H. (2000) Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleuking-3 or granulocyte-macrophage colony-stimulating factor. Molecular and Cellular Biology, 20, 27342742.
  • Lord, B.I., Testa, N.G. & Hendry, J.H. (1975) The relative spatial distributions of CFU-S and CFU-C in the normal mouse femur. Blood, 46, 6572.
  • Mark, M.P., Prince, C.W., Gay, S., Austin, R.L., Bhown, M., Finkelman, R.D. & Butler, W.T. (1987a) A comparative immunocytochemical study on the subcellular distributions of 44 kDa bone phosphoprotein and bone gamma-carboxyglutamic acid (Gla)-containing protein in osteoblasts. Journal of Bone and Mineral Research, 2, 337346.
  • Mark, M.P., Prince, C.W., Oosawa, T., Gay, S., Bronckers, A.L. & Butler, W.T. (1987b) Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones. Journal of Histochemistry and Cytochemistry, 35, 707715.
  • Mark, M.P., Butler, W.T., Prince, C.W., Finkelman, R.D. & Ruch, J.V. (1988) Developmental expression of 44-kDa bone phosphoprotein (osteopontin) and bone gamma-carboxyglutamic acid (Gla)-containing protein (osteocalcin) in calcifying tissues of rat. Differentiation, 37, 123136.
  • Mason, T.M., Lord, B.I. & Hendry, J.H. (1989) The development of spatial distributions of CFU-S and in-vitro CFC in femora of mice of different ages. British Journal of Haematology, 73, 455461.
  • Matrosova, V.Y., Orlovskaya, I.A., Serobyan, N. & Khaldoyanidi, S.K. (2004) Hyaluronic acid facilitates the recovery of hematopoiesis following 5-fluorouracil administration. Stem Cells, 22, 544555.
  • McKee, M.D. & Nanci, A. (1996) Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connective Tissue Research, 35, 197205.
  • Nakase, T., Sugimoto, M., Sato, M., Kaneko, M., Tomita, T., Sugamoto, K., Nomura, S., Kitamura, Y., Yoshikawa, H., Yasui, N., Yonenobu, K. & Ochi, T. (1998) Switch of osteonectin and osteopontin mRNA expression in the process of cartilage-to-bone transition during fracture repair. Acta Histochemica, 100, 287295.
  • Nemir, M., DeVouge, M.W. & Mukherjee, B.B. (1989) Normal rat kidney cells secrete both phosphorylated and nonphosphorylated forms of osteopontin showing different physiological properties. Journal of Biological Chemistry, 264, 1820218208.
  • Nilsson, S.K., Dooner, M.S., Tiarks, C.Y., Weier, H.-U.G. & Quesenberry, P.J. (1997) Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model. Blood, 89, 40134020.
  • Nilsson, S.K., Johnston, H.M., Coverdale, J.A. (2001) Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood, 97, 22932299.
  • Nilsson, S.K., Haylock, D.N., Johnston, H.M., Occhiodoro, T., Brown, T.J. & Simmons, P.J. (2003) Hyaluronan is synthesized by primitive hemopoietic cells, participates in their lodgment at the endosteum following transplantation, and is involved in the regulation of their proliferation and differentiation in vitro. Blood, 101, 856862.
  • Nilsson, S.K., Johnston, H.M., Whitty, G.A., Williams, B., Webb, R.J., Denhardt, D.T., Bertoncello, I., Bendall, L.J., Simmons, P.J. & Haylock, D.N. (2005) Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood, 106, 12321239.
  • O'Regan, A. & Berman, J.S. (2000) Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. International Journal of Experimental Pathology, 81, 373390.
  • O'Regan, A.W., Chupp, G.L., Lowry, J.A., Goetschkes, M., Mulligan, N. & Berman, J.S. (1999) Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. Journal of Immunology, 162, 10241031.
  • Oldberg, A., Franzen, A. & Heinegard, D. (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proceedings of the National Academy of Sciences of the United States of America, 83, 88198823.
  • Papayannopoulou, T., Craddock, C., Nakamoto, B., Priestley, G.V. & Wolf, N.S. (1995) The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proceedings of the National Academy of Sciences of the United States of America, 92, 96479651.
  • Petrow, P.K., Hummel, K.M., Schedel, J., Franz, J.K., Klein, C.L., Muller-Ladner, U., Kriegsmann, J., Chang, P.L., Prince, C.W., Gay, R.E. & Gay, S. (2000) Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis and Rheumatism, 43, 15971605.
  • Reinholt, F.P., Hultenby, K., Oldberg, A. & Heinegard, D. (1990) Osteopontin – a possible anchor of osteoclasts to bone. Proceedings of the National Academy of Sciences of the United States of America, 87, 44734475.
  • Saeki, Y., Mima, T., Ishii, T., Ogata, A., Kobayashi, H., Ohshima, S., Ishida, T., Tabunoki, Y., Kitayama, H., Mizuki, M., Katada, Y., Asaoku, H., Kitano, M., Nishimoto, N., Yoshizaki, K., Maeda, M., Kon, S., Kinoshita, N., Uede, T. & Kawase, I. (2003) Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications. British Journal of Haematology, 123, 263270.
  • Salih, M.A., Ahmed, A.A., Sid  Ahmed, H. & Olcen, P. (1995) An ELISA assay for the rapid diagnosis of acute bacterial meningitis. Annals of Tropical Paediatrics, 15, 273278.
  • Salih, E., Ashkar, S., Gerstenfeld, L.C. & Glimcher, M.J. (1996) Protein kinases of cultured osteoblasts: selectivity for the extracellular matrix proteins of bone and their catalytic competence for osteopontin. Journal of Bone and Mineral Research, 11, 14611473.
  • Salih, E., Ashkar, S., Gerstenfeld, L.C. & Glimcher, M.J. (1997) Identification of the phosphorylated sites of metabolically 32P-labeled osteopontin from cultured chicken osteoblasts. Journal of Biological Chemistry, 272, 1396613973.
  • Schofield, R. (1978) The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells, 4, 725.
  • Shen, Q. & Christakos, S. (2005) The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. Journal of Biological Chemistry, 280, 4058940598.
  • Simmons, P.J., Masinovsky, B., Longenecker, B.M., Berenson, R., Torok-Storb, B. & Gallatin, W.M. (1992) Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood, 80, 388395.
  • Simmons, P.J., Levesque, J.-P. & Zannettino, A. (1997) Adhesion molecules in haemopoiesis. Bailliere's Clinical Haematology, 10, 485505.
  • Smith, J.H. & Denhardt, D.T. (1987) Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. Journal of Cellular Biochemistry, 34, 1322.
  • Smith, L.L. & Giachelli, C.M. (1998) Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin. Experimental Cell Research, 242, 351360.
  • Sorensen, E.S., Rasmussen, L.K., Moller, L., Jensen, P.H., Hojrup, P. & Petersen, T.E. (1994) Localization of transglutaminase-reactive glutamine residues in bovine osteopontin. Biochemical Journal, 304 (Pt 1), 1316.
  • Standal, T., Hjorth-Hansen, H., Rasmussen, T., Dahl, I.M., Lenhoff, S., Brenne, A.T., Seidel, C., Baykov, V., Waage, A., Borset, M., Sundan, A. & Hjertner, O. (2004) Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica, 89, 174182.
  • Stier, S., Ko, Y., Forkert, R., Lutz, C., Neuhaus, T., Grunewald, E., Cheng, T., Dombkowski, D., Calvi, L.M., Rittling, S.R. & Scadden, D.T. (2005) Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. Journal of Experimental Medicine, 201, 17811791.
  • Swanson, G.J., Nomura, S. & Hogan, B.L. (1989) Distribution of expression of 2AR (osteopontin) in the embryonic mouse inner ear revealed by in situ hybridisation. Hearing Research, 41, 169177.
  • Taichman, R.S. (2005) Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood, 105, 26312639.
  • Taichman, R.S. & Emerson, S.G. (1998) The role of osteoblasts in the hematopoietic microenvironment. Stem Cells, 16, 715.
  • Taichman, R.S., Reilly, M.J. & Emerson, S.G. (2000) The hematopoietic microenvironment: osteoblasts and the hematopoietic microenvironment. Hematology, 4, 421426.
  • Takahashi, F., Akutagawa, S., Fukumoto, H., Tsukiyama, S., Ohe, Y., Takahashi, K., Fukuchi, Y., Saijo, N. & Nishio, K. (2002) Osteopontin induces angiogenesis of murine neuroblastoma cells in mice. International Journal of Cancer, 98, 707712.
  • Tavian, M. & Peault, B. (2005) Embryonic development of the human hematopoietic system. International Journal of Developmental Biology, 49, 243250.
  • Tavian, M., Coulombel, L., Luton, D., Clemente, H.S., Dieterlen-Lievre, F. & Peault, B. (1996) Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood, 87, 6772.
  • Vejda, S., Piwocka, K., McKenna, S.L. & Cotter, T.G. (2005) Autocrine secretion of osteopontin results in degradation of I kappa B in Bcr-Abl-expressing cells. British Journal of Haematology, 128, 711721.
  • Visnjic, D., Kalajzic, Z., Rowe, D.W., Katavic, V., Lorenzo, J. & Aguila, H.L. (2004) Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood, 103, 32583264.
  • Weber, G.F., Ashkar, S., Glimcher, M.J. & Cantor, H. (1996) Receptor–ligand interaction between CD44 and osteopontin (Eta-1). Science, 271, 509512.
  • Weber, G.F., Zawaideh, S., Hikita, S., Kumar, V.A., Cantor, H. & Ashkar, S. (2002) Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. Journal of Leukocyte Biology, 72, 752761.
  • Wolf, N.S. (1979) The haemopoietic microenvironment. Clinics in Haematology, 8, 469500.
  • Yokosaki, Y., Matsuura, N., Sasaki, T., Murakami, I., Schneider, H., Higashiyama, S., Saitoh, Y., Yamakido, M., Taooka, Y. & Sheppard, D. (1999) The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. Journal of Biological Chemistry, 274, 3632836334.
  • Yokosaki, Y., Tanaka, K., Higashikawa, F., Yamashita, K. & Eboshida, A. (2005) Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin. Matrix Biology, 24, 418427.
  • Yoshitake, H., Rittling, S.R., Denhardt, D.T. & Noda, M. (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proceedings of the National Academy of Sciences of the United States of America, 96, 81568160.
  • Zhang, J., Niu, C., Ye, L., Huang, H., He, X., Tong, W.G., Ross, J., Haug, J., Johnson, T., Feng, J.Q., Harris, S., Wiedemann, L.M., Mishina, Y. & Li, L. (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature, 425, 836841.
  • Zhu, B., Suzuki, K., Goldberg, H.A., Rittling, S.R., Denhardt, D.T., McCulloch, C.A. & Sodek, J. (2004) Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. Journal of Cellular Physiology, 198, 155167.